What is Rekovelle?

Rekovelle is a drug used in women undergoing an ART cycle, exactly during ovarian stimulation for artificial insemination (AI) or in vitro fertilization (IVF).

The active ingredient of Rekovelle is folitropin delta, which is the hormone FSH obtained recombinantly in the laboratory.

Through the continuous administration of Rekovelle in an IVF cycle, the aim is to provoke multiple follicular development in the ovaries and obtain a greater number of mature eggs for fertilization.

Currently, there are 3 types of Rekovelle marketed that differ in the hormonal dose they contain: Rekovelle 12 mcg/0.36 ml, Rekovelle 36 mcg/1.08 ml and Rekovelle 72 mcg/2.16 ml.

This drug is administered subcutaneously with the help of a pre-filled pen that is easy to apply.

Community and Support

At inviTRA we work to make monthly and rigorous information accessible to everyone. If this article has helped you, consider supporting us so we can continue accompanying more people on their journey to parenthood.

Author

Zaira Salvador

B.Sc., M.Sc.

Embryologist

Bachelor's Degree in Biotechnology from the Technical University of Valencia (UPV). Biotechnology Degree from the National University of Ireland en Galway (NUIG) and embryologist specializing in Assisted Reproduction, with a Master's Degree in Biotechnology of Human Reproduction from the University of Valencia (UV) and the Valencian Infertility Institute (IVI) More information about Zaira Salvador

License: 3185-CV